Bøger i Cancer Drug Discovery and Development serien
-
1.005,95 kr. - Bog
- 1.005,95 kr.
-
1.804,95 kr. This book provides insight into established practices and research into apoptosis and senescence. The volume thoroughly examines novel and emerging techniques and research in the fields of cell death pathways, senescence growth arrest, drugs and resistance, DNA damage response, and other topics that still hold mysteries for researchers.
- Bog
- 1.804,95 kr.
-
1.619,95 kr. While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.
- Bog
- 1.619,95 kr.
-
2.089,95 kr. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island).
- Bog
- 2.089,95 kr.
-
2.116,95 kr. Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments.
- Bog
- 2.116,95 kr.
-
1.852,95 kr. This book presents the first comprehensive exploration of the dynamic potential of microtubules anti-cancer targets. Written by leading anti-cancer researchers, this groundbreaking volume collects the most current microtubule research available and investigates the potential of microtubules in cancer therapy.
- Bog
- 1.852,95 kr.
-
1.628,95 kr. While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.
- Bog
- 1.628,95 kr.
-
- Basic and Clinical Biology
2.140,95 kr. Transforming Growth Factor- ss in Cancer Therapy, Vols. 1 and 2, provides a compendium of findings about the role of transforming growth factor- ss (TGF- ss) in cancer treatment and therapy.
- Bog
- 2.140,95 kr.
-
- Cancer Treatment and Therapy
1.804,95 kr. Transforming Growth Factor- ss in Cancer Therapy, Vols. 1 and 2, provides a compendium of findings about the role of transforming growth factor- ss (TGF- ss) in cancer treatment and therapy. The companion volume details the role of TGF- ss on basic and clinical biology.
- Bog
- 1.804,95 kr.
-
2.103,95 kr. The classical example is gemcitabine, now one of the most widely applied deoxynucleoside analogs, used for the (combination) treatment of non-small cell lung cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
- Bog
- 2.103,95 kr.
-
1.688,95 kr. This book describes the principles underlying targeted hormonal treatments, assesses the actions of new and established agents, and illustrates the new applications of hormonal chemoprevention for breast cancer.
- Bog
- 1.688,95 kr.
-
- Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches
2.698,95 kr. Their joint efforts are gradually peeling away the mysteries surrounding the genesis and progression of these tumors and inroads are being steadily made into understanding why they resist therapies.
- Bog
- 2.698,95 kr.
-
1.161,95 kr. This book describes the principles underlying targeted hormonal treatments, assesses the actions of new and established agents, and illustrates the new applications of hormonal chemoprevention for breast cancer.
- Bog
- 1.161,95 kr.
-
- The Molecular Basis of Cancer and Other Diseases
1.658,95 kr. Leading scientists summarize the latest findings on signal transduction and cell cycle regulation and describe the effort to design and synthesize inhibiting molecules, as well as to evaluate their biochemical and biological activities.
- Bog
- 1.658,95 kr.
-
2.090,95 kr. The classical example is gemcitabine, now one of the most widely applied deoxynucleoside analogs, used for the (combination) treatment of non-small cell lung cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
- Bog
- 2.090,95 kr.
-
- Cancer Treatment and Therapy
2.689,95 kr. Transforming Growth Factor- ss in Cancer Therapy, Vols. 1 and 2, provides a compendium of findings about the role of transforming growth factor- ss (TGF- ss) in cancer treatment and therapy. The companion volume details the role of TGF- ss on basic and clinical biology.
- Bog
- 2.689,95 kr.
-
2.100,95 kr. - Bog
- 2.100,95 kr.
-
2.473,95 kr. This book provides insight into established practices and research into apoptosis and senescence. The volume thoroughly examines novel and emerging techniques and research in the fields of cell death pathways, senescence growth arrest, drugs and resistance, DNA damage response, and other topics that still hold mysteries for researchers.
- Bog
- 2.473,95 kr.
-
- Basic and Clinical Biology
2.408,95 kr. Transforming Growth Factor- ss in Cancer Therapy, Vols. 1 and 2, provides a compendium of findings about the role of transforming growth factor- ss (TGF- ss) in cancer treatment and therapy.
- Bog
- 2.408,95 kr.
-
- The Molecular Basis of Cancer and Other Diseases
1.650,95 kr. Leading scientists summarize the latest findings on signal transduction and cell cycle regulation and describe the effort to design and synthesize inhibiting molecules, as well as to evaluate their biochemical and biological activities.
- Bog
- 1.650,95 kr.
-
2.078,95 kr. The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island).
- Bog
- 2.078,95 kr.
-
1.782,95 kr. This volume will outline how to recreate the tumor microenvironment, to culture primary tumors without the need for developmental priming factors, and to deliver targeted therapeutics in a manner that recapitulates pharmacokinetics in vivo.
- Bog
- 1.782,95 kr.
-
- Molecular Mechanisms and Clinical Applications
2.099,95 kr. Cisplatin is still an irreplaceable component of a regimen that produces high cure rates in even advanced nonseminomatous germ-cell cancers, and is widely used in the treatment of ovarian cancers and other gynecologic cancers, head and neck, and numerous other tumor types.
- Bog
- 2.099,95 kr.
-
1.050,95 kr. This volume will be the first to provide a comprehensive description of tumor dormancy. The volume will serve as a fundamental instrument for every researcher and clinician interested in the field of tumor dormancy as well as a means of disseminating stimulating concepts and prompting the development of innovative technological solutions.
- Bog
- 1.050,95 kr.
-
2.386,95 kr. A comprehensive review of the recent developments in DNA repair research that have potential for translational applications.
- Bog
- 2.386,95 kr.
-
2.320,95 kr. A comprehensive review of the recent developments in DNA repair research that have potential for translational applications.
- Bog
- 2.320,95 kr.
-
2.085,95 kr. As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents that may have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR.
- Bog
- 2.085,95 kr.
-
- Molecular Mechanisms and Clinical Applications
1.852,95 kr. Cisplatin is still an irreplaceable component of a regimen that produces high cure rates in even advanced nonseminomatous germ-cell cancers, and is widely used in the treatment of ovarian cancers and other gynecologic cancers, head and neck, and numerous other tumor types.
- Bog
- 1.852,95 kr.
-
1.852,95 kr. Checkpoint Responses in Cancer Therapy summarizes the advances made over the past 20 years, identifying components of cell-cycle checkpoints and their molecular regulation during checkpoint activation and validating the use of checkpoint proteins as targets for the development of anticancer drugs.
- Bog
- 1.852,95 kr.
-
1.360,95 kr. A variety of cutting-edge imaging techniques, including their use for best practice, are addressed in this book. The book also provides examples of results found in both pre-clinical and clinical studies. This comprehensive text covers the entire spectrum of in vivo imaging for oncology.
- Bog
- 1.360,95 kr.